Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,746,604
  • Shares Outstanding, K 1,132,909
  • Annual Sales, $ 15,846 M
  • Annual Income, $ -559,000 K
  • EBIT $ 1,505 M
  • EBITDA $ 2,658 M
  • 60-Month Beta 0.87
  • Price/Sales 1.34
  • Price/Cash Flow 5.34
  • Price/Book 3.24

Options Overview Details

View History
  • Implied Volatility 35.20% ( -1.85%)
  • Historical Volatility 32.60%
  • IV Percentile 38%
  • IV Rank 20.95%
  • IV High 66.03% on 07/10/24
  • IV Low 27.03% on 06/11/24
  • Put/Call Vol Ratio 1.65
  • Today's Volume 24,385
  • Volume Avg (30-Day) 14,967
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 583,454
  • Open Int (30-Day) 547,532

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.68
  • Number of Estimates 6
  • High Estimate 0.73
  • Low Estimate 0.63
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -30.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.18 +1.86%
on 11/06/24
19.31 -9.37%
on 11/06/24
+0.22 (+1.27%)
since 10/07/24
3-Month
16.91 +3.49%
on 08/13/24
19.31 -9.37%
on 11/06/24
+0.71 (+4.23%)
since 08/07/24
52-Week
8.55 +104.80%
on 11/10/23
19.31 -9.37%
on 11/06/24
+8.46 (+93.58%)
since 11/07/23

Most Recent Stories

More News
TEVA Stock Down 7% Despite Q3 Earnings & Sales Beat, Guidance Increase

Teva Pharmaceutical Industries TEVA reported third-quarter 2024 adjusted earnings of 69 cents per share, which beat the Zacks Consensus Estimate of 65 cents. Adjusted earnings rose 15% year over year.Revenues...

NVO : 107.63 (+2.15%)
JNJ : 156.73 (-0.73%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript

TEVA earnings call for the period ending September 30, 2024.

TEVA : 17.50 (+0.40%)
What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

The earnings season for the drug/biotech sector is now in its final lap, with some large biotech and generic drug companies due to report their third-quarter 2024 results this week.The remaining large...

NVO : 107.63 (+2.15%)
VTRS : 13.18 (+13.52%)
TEVA : 17.50 (+0.40%)
GILD : 97.90 (+6.77%)
MRNA : 50.28 (-2.95%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 5.56 (-1.59%)
NTRBW : 1.5500 (+6.90%)
LLY : 797.45 (+2.71%)
NVS : 107.08 (+0.25%)
TEVA : 17.50 (+0.40%)
AMRX : 8.61 (+1.29%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 5.56 (-1.59%)
NTRBW : 1.5500 (+6.90%)
LLY : 797.45 (+2.71%)
NVS : 107.08 (+0.25%)
TEVA : 17.50 (+0.40%)
AMRX : 8.61 (+1.29%)
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for the industry. The stock has also outperformed the sector and the S&P 500, as...

SNY : 51.73 (+0.92%)
JNJ : 156.73 (-0.73%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Ozempic Medicare Negotiations Target Big Pharma in 2027

The anticipated 2027 Medicare drug negotiations are expected to impact several blockbuster drugs, with Novo Nordisk’s (NOVO) Ozempic, Pfizer’s (PFE) Ibrance and Xtandi, and GSK’s (GSK) Trelegy Ellipta...

PFE : 27.46 (+0.37%)
GSK : 36.66 (+2.12%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...

ALZN : 1.5000 (+3.45%)
VNDA : 5.02 (+2.66%)
ITCI : 90.51 (+1.20%)
TEVA : 17.50 (+0.40%)
ABBV : 200.51 (-0.34%)
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript

TEVA earnings call for the period ending June 30, 2024.

TEVA : 17.50 (+0.40%)
Option Volatility And Earnings Report For July 29 – August 2

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

AAPL : 227.48 (+2.14%)
AMD : 149.82 (+3.25%)
AMZN : 210.05 (+1.43%)
PFE : 27.46 (+0.37%)
COIN : 255.58 (+0.50%)
META : 591.70 (+3.44%)
INTC : 26.23 (+4.71%)
XOM : 121.15 (+0.12%)
BA : 150.98 (+2.60%)
PYPL : 81.35 (-0.07%)
SBUX : 96.12 (+0.04%)
MCD : 294.66 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets,...

See More

Key Turning Points

3rd Resistance Point 18.19
2nd Resistance Point 18.03
1st Resistance Point 17.76
Last Price 17.50
1st Support Level 17.33
2nd Support Level 17.17
3rd Support Level 16.90

See More

52-Week High 19.31
Last Price 17.50
Fibonacci 61.8% 15.20
Fibonacci 50% 13.93
Fibonacci 38.2% 12.66
52-Week Low 8.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar